Frazier Life Sciences Viii, L.P. Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Frazier Life Sciences Viii, L.P. is > 10% Shareholder of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 8.76 Million shares of ARQT, which is worth approximately $131 Million. The most recent transaction as insider was on Oct 24, 2023, when has been sold 80,000 shares (Common Stock) at a price of $2.5 per share, resulting in proceeds of $200,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.76M

0% 3M change

0% 12M change

Total Value Held $131 Million

Frazier Life Sciences VIII, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 24 2023	BUY Open market or private purchase	$200,000 $2.5 p/Share	80,000 Added 0.9%	8,764,232 Common Stock
Aug 05 2022	BUY Open market or private purchase	$5,000,000 $20.0 p/Share	250,000 Added 2.8%	8,684,232 Common Stock
May 10 2021	SELL Other acquisition or disposition	-	2,108,558 Reduced 20.0%	8,434,232 Common Stock

Also insider at

ALPN

ALPINE IMMUNE SCIENCES, INC. Healthcare

> 10% Shareholder

FLS